Simplex Trading
AIMT

Simplex Trading’s Aimmune Therapeutics AIMT Stock Holding History

Simplex Trading’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-309
Closed -$445K – 8750
2020
Q1 		$445K Buy
309
+30
+11% +$767 ﹤0.01% 2722
2019
Q4 		$933K Buy
279
+49
+21% +$1.37K ﹤0.01% 2153
2019
Q3 		$481K Buy
230
+89
+63% +$1.82K ﹤0.01% 2663
2019
Q2 		$293K Buy
141
+56
+66% +$1.15K ﹤0.01% 3097
2019
Q1 		$189K Buy
85
+30
+55% +$706 ﹤0.01% 3686
2018
Q4 		$131K Sell
55
-435
-89% -$11.3K ﹤0.01% 3583
2018
Q3 		$1.34M Buy
490
+18
+4% +$509 ﹤0.01% 1594
2018
Q2 		$1.27M Buy
472
+451
+2,148% +$13.8K 0.01% 1580
2018
Q1 		$3K Sell
21
-54
-72% -$1.9K ﹤0.01% 5131
2017
Q4 		$27K Buy
75
+62
+477% +$2K ﹤0.01% 3046
2017
Q3 		$8K Sell
13
-22
-63% -$474 ﹤0.01% 4035
2017
Q2 		$5K Buy
35
+8
+30% +$153 ﹤0.01% 4675
2017
Q1 		$5K Buy
+27
New +$554 ﹤0.01% 4666

Other funds holding AIMT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Simplex Trading's AIMT Position: Q2 2020 in Review

Simplex Trading sold out of Aimmune Therapeutics (AIMT) in Q2 2020, closing a stake of 200 shares — an estimated $3.4K sold.

Simplex Trading first reported a position in AIMT in Q3 2016 and held it in 9 quarters. The position peaked at $1.06M in Q4 2019. 165 funds tracked by Wall St. Rank hold AIMT as of Q2 2020.

  • Simplex Trading reported no remaining Aimmune Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Simplex Trading sold 200 Aimmune Therapeutics shares in Q2 2020, an estimated $3.4K.
  • Simplex Trading first reported a position in Aimmune Therapeutics in Q3 2016 and held it in 9 quarters.
  • Simplex Trading's Aimmune Therapeutics position peaked at $1.06M in Q4 2019.
  • 165 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q2 2020.

Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.